UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Triage‐HF Plus: a novel device‐based remote monitoring pathway to identify worsening heart failure

ESC Heart Failure, 2020-02, Vol.7 (1), p.107-116

2020

Volltextzugriff (PDF)

Rationale and study design of the REM-HF study: remote management of heart failure using implanted devices and formalized follow-up procedures

European journal of heart failure, 2014-09, Vol.16 (9), p.1039-1045

2014

Volltextzugriff (PDF)

Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial

The Lancet (British edition), 2022-12, Vol.400 (10369), p.2199-2209

2022

Volltextzugriff (PDF)

Remote management of heart failure using implantable electronic devices

European heart journal, 2017-08, Vol.38 (30), p.2352-2360

2017

Volltextzugriff (PDF)

Abstract 15659: Dynamic Device Derived Heart Failure Risk Score as a Predictor of Heart Failure Hospitalisation

Circulation (New York, N.Y.), 2020-11, Vol.142 (Suppl_3 Suppl 3), p.A15659-A15659

2020

Volltextzugriff (PDF)

Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics

European heart journal, 2023-08, Vol.44 (31), p.2966-2977

2023

Volltextzugriff (PDF)

Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trial

European heart journal, 2024-04, Vol.45 (16), p.1410-1426

2024

Volltextzugriff (PDF)

Impact of remote monitoring on clinical outcomes for patients with heart failure and atrial fibrillation: results from the REM‐HF trial

European journal of heart failure, 2020-03, Vol.22 (3), p.543-553

2020

Volltextzugriff (PDF)

Effect of correcting iron deficiency on the risk of serious infection in heart failure: Insights from the IRONMAN trial

European journal of heart failure, 2024-10

2024

Volltextzugriff (PDF)

Improving the secondary prevention of ST-elevation myocardial infarction

Clinical medicine (London, England), 2019-06, Vol.19 (Suppl 3), p.54-55

2019

Volltextzugriff (PDF)

Improving the secondary prevention of ST-elevation myocardial infarction

Clinical medicine (London, England), 2019-06, Vol.19 (3), p.s54-s55

2019

Volltextzugriff (PDF)

Prevalence and prognostic significance of device-detected subclinical atrial fibrillation in patients with heart failure and reduced ejection fraction

International journal of cardiology, 2020-08, Vol.312, p.64-70

2020

Volltextzugriff (PDF)

The Impact of Ferric Derisomaltose on Cardiovascular and Noncardiovascular Events in Patients With Anemia, Iron Deficiency, and Heart Failure With Reduced Ejection Fraction

Journal of cardiac failure, 2024-05, Vol.30 (5), p.682-690

2024

Volltextzugriff (PDF)

The primary prevention implantable cardioverter-defibrillator (ICD) during the COVID-19 pandemic

The British journal of cardiology, 2021-01, Vol.28 (2)

2021

Volltextzugriff (PDF)

Neurohumoral effects of the new orally active renin inhibitor, aliskiren, in chronic heart failure

European journal of heart failure, 2007-11, Vol.9 (11), p.1120-1127

2007

Volltextzugriff (PDF)

The dual endothelin converting enzyme/neutral endopeptidase inhibitor SLV-306 (daglutril), inhibits systemic conversion of big endothelin-1 in humans

Life sciences (1973), 2012-10, Vol.91 (13-14), p.743-748

2012

Volltextzugriff (PDF)

Clinical experience with endothelin receptor antagonists in chronic heart failure

Heart failure reviews, 2001-12, Vol.6 (4), p.317-323

2001

Volltextzugriff (PDF)

Effects of Neutral Endopeptidase (Neprilysin) Inhibition on the Response to Other Vasoactive Peptides in Small Human Resistance Arteries: Studies with Thiorphan and Omapatrilat

Cardiovascular therapeutics, 2014-02, Vol.32 (1), p.13-18

2014

Volltextzugriff (PDF)

Effects of aldosterone receptor blockade in patients with mild-moderate heart failure taking a beta-blocker

European journal of heart failure, 2007-04, Vol.9 (4), p.429-434

2007

Volltextzugriff (PDF)

Is the pregnancy hormone relaxin also a vasodilator peptide secreted by the heart?

Circulation (New York, N.Y.), 2002-07, Vol.106 (3), p.292-295

2002

Volltextzugriff (PDF)

Is a target culture in health care always compatible with efficient use of resources? A cost-effectiveness analysis of an intervention to achieve thrombolysis targets

Journal of public health (Oxford, England), 2006-03, Vol.28 (1), p.31-34

2006

Volltextzugriff (PDF)

Abstract 10571: Triage HF Plus: Predicting, Preventing and Managing Heart Failure Episodes in Ambulatory Patients With a Cardiac Implantable Electronic Device Using Device Based Diagnostics and Automated Carelink Alerts

Circulation (New York, N.Y.), 2018-11, Vol.138 (Suppl_1 Suppl 1), p.A10571-A10571

2018

Volltextzugriff (PDF)

Characterisation of the pharmacological actions in humans of multiple vasoactive enzyme inhibitors with therapeutic potential in heart failure

Seed, Alison

2007

Volltextzugriff (PDF)

Corrigendum to "Effects of aldosterone receptor blockade in patients with mild-moderate heart failure taking a beta-blocker" [European Journal of Heart Failure 9/4 (2007) 429-434]

European journal of heart failure, 2007-10, Vol.9 (10), p.1074-1074

2007

Volltextzugriff (PDF)

Acute endothelin a receptor blockade in heart failure

Circulation (New York, N.Y.), 2001-05, Vol.103 (18), p.E94-E94

2001

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(44)

Publikationsform

Sprache

Englisch
(50)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Triage‐HF Plus: a novel device‐based remote monitoring pathway to identify worsening heart failure

Rationale and study design of the REM-HF study: remote management of heart failure using implanted devices and formalized follow-up procedures

Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial

Remote management of heart failure using implantable electronic devices

Abstract 15659: Dynamic Device Derived Heart Failure Risk Score as a Predictor of Heart Failure Hospitalisation

Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics

Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trial

Impact of remote monitoring on clinical outcomes for patients with heart failure and atrial fibrillation: results from the REM‐HF trial

Effect of correcting iron deficiency on the risk of serious infection in heart failure: Insights from the IRONMAN trial

Improving the secondary prevention of ST-elevation myocardial infarction

Improving the secondary prevention of ST-elevation myocardial infarction

Prevalence and prognostic significance of device-detected subclinical atrial fibrillation in patients with heart failure and reduced ejection fraction

The Impact of Ferric Derisomaltose on Cardiovascular and Noncardiovascular Events in Patients With Anemia, Iron Deficiency, and Heart Failure With Reduced Ejection Fraction

The primary prevention implantable cardioverter-defibrillator (ICD) during the COVID-19 pandemic

Neurohumoral effects of the new orally active renin inhibitor, aliskiren, in chronic heart failure

The dual endothelin converting enzyme/neutral endopeptidase inhibitor SLV-306 (daglutril), inhibits systemic conversion of big endothelin-1 in humans

Clinical experience with endothelin receptor antagonists in chronic heart failure

Effects of Neutral Endopeptidase (Neprilysin) Inhibition on the Response to Other Vasoactive Peptides in Small Human Resistance Arteries: Studies with Thiorphan and Omapatrilat

Effects of aldosterone receptor blockade in patients with mild-moderate heart failure taking a beta-blocker

Is the pregnancy hormone relaxin also a vasodilator peptide secreted by the heart?

Is a target culture in health care always compatible with efficient use of resources? A cost-effectiveness analysis of an intervention to achieve thrombolysis targets

Abstract 10571: Triage HF Plus: Predicting, Preventing and Managing Heart Failure Episodes in Ambulatory Patients With a Cardiac Implantable Electronic Device Using Device Based Diagnostics and Automated Carelink Alerts

Characterisation of the pharmacological actions in humans of multiple vasoactive enzyme inhibitors with therapeutic potential in heart failure

Corrigendum to "Effects of aldosterone receptor blockade in patients with mild-moderate heart failure taking a beta-blocker" [European Journal of Heart Failure 9/4 (2007) 429-434]

Acute endothelin a receptor blockade in heart failure

Suchergebnisse filtern